These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28666413)

  • 1. Co-morbidity and polypharmacy in Parkinson's disease: insights from a large Scottish primary care database.
    McLean G; Hindle JV; Guthrie B; Mercer SW
    BMC Neurol; 2017 Jul; 17(1):126. PubMed ID: 28666413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comorbidity and polypharmacy in chronic heart failure: a large cross-sectional study in primary care.
    Baron-Franco B; McLean G; Mair FS; Roger VL; Guthrie B; Mercer SW
    Br J Gen Pract; 2017 May; 67(658):e314-e320. PubMed ID: 28396366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbid conditions associated with Parkinson's disease: A longitudinal and comparative study with Alzheimer disease and control subjects.
    Santos García D; Suárez Castro E; Expósito I; de Deus T; Tuñas C; Aneiros A; López Fernández M; Núñez Arias D; Bermúdez Torres M
    J Neurol Sci; 2017 Feb; 373():210-215. PubMed ID: 28131190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbidity and polypharmacy in people with dementia: insights from a large, population-based cross-sectional analysis of primary care data.
    Clague F; Mercer SW; McLean G; Reynish E; Guthrie B
    Age Ageing; 2017 Jan; 46(1):33-39. PubMed ID: 28181629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple physical and mental health comorbidity in adults with intellectual disabilities: population-based cross-sectional analysis.
    Cooper SA; McLean G; Guthrie B; McConnachie A; Mercer S; Sullivan F; Morrison J
    BMC Fam Pract; 2015 Aug; 16():110. PubMed ID: 26310664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polypharmacy and Hyperpolypharmacy in Older Individuals with Parkinson's Disease: A Systematic Review and Meta-Analysis.
    Bhagavathula AS; Tesfaye W; Vidyasagar K; Fialova D
    Gerontology; 2022; 68(10):1081-1090. PubMed ID: 35026767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, Patterns and Predictors of Psychotropic Polypharmacy Among Elderly Individuals with Parkinson's Disease In Long Term Care Settings In The United States.
    Bhattacharjee S; Goldstone L; Warholak T
    J Parkinsons Dis; 2016; 6(1):247-55. PubMed ID: 26756742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of polypharmacy and Parkinson's disease prevalence.
    Chen Y; Yu Z
    Bratisl Lek Listy; 2021; 122(2):158-160. PubMed ID: 33502886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic migraine, comorbidity, and socioeconomic deprivation: cross-sectional analysis of a large nationally representative primary care database.
    McLean G; Mercer SW
    J Comorb; 2017; 7(1):89-95. PubMed ID: 29299439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in Scotland: implications for treatment burden.
    Gallacher KI; Batty GD; McLean G; Mercer SW; Guthrie B; May CR; Langhorne P; Mair FS
    BMC Med; 2014 Oct; 12():151. PubMed ID: 25280748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental risk factors for Parkinson's disease and parkinsonism: the Geoparkinson study.
    Dick FD; De Palma G; Ahmadi A; Scott NW; Prescott GJ; Bennett J; Semple S; Dick S; Counsell C; Mozzoni P; Haites N; Wettinger SB; Mutti A; Otelea M; Seaton A; Söderkvist P; Felice A;
    Occup Environ Med; 2007 Oct; 64(10):666-72. PubMed ID: 17332139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacy increases the risk of Parkinson's disease in older people in Taiwan: a population-based study.
    Lai SW; Su LT; Lin CH; Tsai CH; Sung FC; Hsieh DP
    Psychogeriatrics; 2011 Sep; 11(3):150-6. PubMed ID: 21951955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of polypharmacy in a Scottish primary care population.
    Payne RA; Avery AJ; Duerden M; Saunders CL; Simpson CR; Abel GA
    Eur J Clin Pharmacol; 2014 May; 70(5):575-81. PubMed ID: 24487416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospital care for mental health and substance abuse conditions in Parkinson's disease.
    Willis AW; Thibault DP; Schmidt PN; Dorsey ER; Weintraub D
    Mov Disord; 2016 Dec; 31(12):1810-1819. PubMed ID: 27943472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk and adverse outcomes of fractures in patients with Parkinson's disease: two nationwide studies.
    Huang YF; Cherng YG; Hsu SP; Yeh CC; Chou YC; Wu CH; Chen TL; Liao CC
    Osteoporos Int; 2015 Jun; 26(6):1723-32. PubMed ID: 25672807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticholinergic burden in Parkinson's disease inpatients.
    Lertxundi U; Isla A; Solinis MA; Domingo-Echaburu S; Hernandez R; Peral-Aguirregoitia J; Medrano J
    Eur J Clin Pharmacol; 2015 Oct; 71(10):1271-7. PubMed ID: 26254777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges of treatment adherence in older patients with Parkinson's disease.
    Bainbridge JL; Ruscin JM
    Drugs Aging; 2009; 26(2):145-55. PubMed ID: 19220071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes in patients with idiopathic Parkinson's disease.
    Becker C; Brobert GP; Johansson S; Jick SS; Meier CR
    Diabetes Care; 2008 Sep; 31(9):1808-12. PubMed ID: 18559656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug Safety Analysis in a Real-Life Cohort of Parkinson's Disease Patients with Polypharmacy.
    Müller-Rebstein S; Trenkwalder C; Ebentheuer J; Oertel WH; Culmsee C; Höglinger GU
    CNS Drugs; 2017 Dec; 31(12):1093-1102. PubMed ID: 29139041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease and risk of prostate cancer: A Danish population-based case-control study, 1995-2010.
    Jespersen CG; Nørgaard M; Borre M
    Cancer Epidemiol; 2016 Dec; 45():157-161. PubMed ID: 27838564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.